AstraZeneca experiences significant sales growth due to introduction of new drugs

By Sean Galea-Pace
The pharmaceutical manufacturer, AstraZeneca, has seen considerable sales growth due to the increased demand in its new drugs during the third quarter...

The pharmaceutical manufacturer, AstraZeneca, has seen considerable sales growth due to the increased demand in its new drugs during the third quarter, Reuters reports.

With sales rising 8% in constant currencies, shares in the group increased 2% in early trading on Thursday (8 November).

Since 2012, AstraZeneca has experienced a significant reduction in patents on older drugs, however, with the implantation of 10 new medicines, has seen a growth of 85% during the last quarter.

See more:

The medicines include Imfinzi and Tagrisso which can be used for lung cancer, Fasenra to treat severe asthma and Lynparza for ovarian cancer.

The firm also hopes for success for Farxiga, which can be used to help diabetes and reduce heart risks with the drugmaker predicting years of continued improvement for its medicines.

China has seen a 32% increase in the quarter with AstraZeneca continuing to beat competitors in the world’s second biggest drugs market.

Chief Executive, Pascal Soriot, said: “Today marks an important day for the future of AstraZeneca, with the performance in the quarter and year to date showing what we expect will be the start of a period of sustained growth for years to come.”

Share

Featured Articles

Elisabeth Brinton on the Microsoft Cloud for Sustainability

Microsoft’s Elisabeth Brinton discusses the Microsoft Cloud for Sustainability programme & how manufacturers are being supported by their new technology

Aiimi’s Head of Solution Engineering Matt Eustace on risks

Aiimi utilises AI to provide businesses insights that eliminate risks ‒ including how to manage sanctioned individuals in your supply chain

5 minutes with Nicolai Peitersen, co-founder of Wikifactory

Nicolai Peitersen, co-founder of Wikifactory, shares his knowledge on the Internet of Production, working in Shenzhen and supply chain logistics

Three steps to building a resilient enterprise ecosystem

Procurement & Supply Chain

Chocolate manufacturer Venchi on sustainable packaging

Procurement & Supply Chain

Sustainability goals in manufacturing need a boost with AI

AI & Automation